Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
Ppublish 71 citations
Electronic publication date
May 9, 2014

View on Pubmed.gov 23975386 | View on doi.org 10.1007/s00281-...

Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.

Search for publications in this journal Semin Immunopathol - 35(6):657-70

Abstract

Unlike adaptive immune cells that require antigen recognition and functional maturation during infection, innate lymphoid cells (ILCs) usually respond to pathogens promptly and serve as the first line of defense in infectious diseases. RAR-related orphan receptor (RORγt)⁺ group 3 ILCs are one of the innate cell populations that have recently been intensively studied. During the fetal stage of development, RORγt⁺ group 3 ILCs (e.g., lymphoid tissue inducer cells) are required for lymphoid organogenesis. In adult mice, RORγt⁺ group 3 ILCs are abundantly present in the gut to exert immune defensive functions. Under certain circumstances, however, RORγt⁺ group 3 ILCs can be pathogenic and contribute to intestinal inflammation. Aryl hydrocarbon receptor (Ahr), a ligand-dependent transcriptional factor, is widely expressed by various immune and non-immune cells. In the gut, the ligand for Ahr can be derived/generated from diet, microflora, and/or host cells. Ahr has been shown to regulate different cell populations in the immune system including RORγt⁺ group 3 ILCs, T helper (Th)17/22 cells, γδT cells, regulatory T cells (Tregs), Tr1 cells, and antigen presenting cells. In this review, we will focus on the development and function of RORγt⁺ group 3 ILCs, and discuss the role of Ahr in intestinal immunity and inflammation in mice and in humans. A better understanding of the function of Ahr in the gut is important for developing new therapeutic means to target Ahr in future treatment of infectious and autoimmune diseases.

References

Cell. 1996 Jan 26;84(2):321-30

J Immunol. 2006 Jul 1;177(1):566-73

Microbes Infect. 2010 Mar;12(3):218-26

J Exp Med. 2007 Jun 11;204(6):1267-72

Cited by 71 citations (total)

Journal Article Research Support, N.I.H., Extramural

Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner.

Electronic publication date May 11, 2021

Search for publications in this journal JCI Insight

Philip B Busbee [...] Prakash S Nagarkatti et al.

Colitis, an inflammatory bowel disease, is caused by a variety of factors, but luminal microbiota are thought to play crucial...

Journal Article Research Support, Non-U.S. Gov't

Indol-3-Carbinol and Quercetin Ameliorate Chronic DSS-Induced Colitis in C57BL/6 Mice by AhR-Mediated Anti-Inflammatory Mechanisms.

Electronic publication date April 24, 2021

Search for publications in this journal Int J Environ Res Public Health

Sina Riemschneider [...] Jörg Lehmann et al.

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are multifactorial inflammatory disorders of the gastrointestinal tract, characterised...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances